Analysis of Application of Disease Basic Diagnosis and Treatment Module into Cost Management——Taking Children with Respiratory Infection/Inflammation

China Health Insurance ›› 2022, Vol. 0 ›› Issue (5) : 95-97.

China Health Insurance ›› 2022, Vol. 0 ›› Issue (5) : 95-97. DOI: 10.19546/j.issn.1674-3830.2022.5.020
Medical Viewpoint

Analysis of Application of Disease Basic Diagnosis and Treatment Module into Cost Management——Taking Children with Respiratory Infection/Inflammation

Author information +
History +

Abstract

Objective: The paper explores the effect of disease basic diagnosis and treatment module in the cost management and proposes its application. Methods: The clinical data of 103 children with respiratory infection/inflammation (< 17 years old) who received inpatient treatment before and after the application of basic diseases diagnosis and treatment module in the Second Affiliated Hospital of Guangxi University of Science and Technology were collected. The changes of length of stay, total hospitalization cost, drug cost, proportion of drug cost and rational use of antibiotics were analyzed before and after the application. Results: After using the disease basic diagnosis and treatment module to manage the cost, the length of hospitalization of DRG was 3d, the total hospitalization cost was 1799.23 yuan, the drug cost was 487.02 yuan, and the drug cost accounted for 32.47%, which were lower than or shorter than before 5d, 2429.85 yuan, 924.57 yuan, 39.02% (P < 0.05). The rationality of antibiotic use was 94.44%, which was higher than 81.63% before application (P < 0.05). Conclusion: Using disease basic diagnosis and treatment module for cost management can standardize clinical diagnosis and treatment behavior, improve medical service quality and achieve accurate management.

Key words

disease basic diagnosis and treatment module / DRG / cost management

Cite this article

Download Citations
Analysis of Application of Disease Basic Diagnosis and Treatment Module into Cost Management——Taking Children with Respiratory Infection/Inflammation[J]. China Health Insurance. 2022, 0(5): 95-97 https://doi.org/10.19546/j.issn.1674-3830.2022.5.020

References

[1] 常文虎. 医疗服务支付方式的选择与管理[M].北京:人民卫生出版社,2011:52.
[2] 申昆玲,杨永弘.要更进一步加强儿科抗生素的应用与管理[J].中国研究型医院,2017,4(3):44.
[3] 朱士俊,鲍玉荣,刘海一,等.按DRGs付费的应用研究[J].中国医疗保险,2010,(6):26-28.
[4] 张肖肖,王力红,仇叶龙,等.基于DRGs平台的临床医师团队医疗质量评价研究[J].中国医院,2017,21(1):31-33.

Accesses

Citation

Detail

Sections
Recommended

/